Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2024 - Mental Daily. All Rights Reserved.
Clinical

Study finds psilocybin treatment effective for affective disorders for up to one year

Staff Writer
Staff Writer 3 years ago
Updated 2022/02/16 at 12:07 AM
Share
SHARE

Researchers at Johns Hopkins have made new advancements in their research of the psychedelic compound psilocybin for the treatment of affective disorders.

According to their findings published in the Journal of Psychopharmacology, psilocybin may relieve symptoms associated with major depressive disorder for at least one year, when taken in conjunction with supportive psychotherapy.

More than 20 participants were recruited in the study, all of which had a long history of depression. The participants were mostly white, in mid-adulthood, and women.

“Participants were randomized to an immediate or delayed (8 weeks) treatment condition in which they received two doses of psilocybin with supportive psychotherapy,” the authors explained.

“Twenty-four participants completed both psilocybin sessions and were followed through 12 months following their second dose.”

The Johns Hopkins team unveiled that the anti-depressant effects from psilocybin were not only significant and immediate, but also had a long duration, making it an ideal new treatment for certain affective disorders.

“These findings demonstrate that the substantial antidepressant effects of psilocybin-assisted therapy may be durable at least through 12 months following acute intervention in some patients,” the authors determined.

You Might Also Like

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

Dementia risk factors differ by ethnicity, according to new research

Researchers investigate how endocannabinoids regulate the brain’s stress response

Study shows the risk of eating disorders may be lower among vegans

TAGGED: mental health, psilocybin, psychedelics
Staff Writer February 15, 2022
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article How exercising regularly may help boost vaccine antibodies
Next Article How gut fungi may influence neuroimmunity and social behavior

Recommended

Clinical

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

1 Min Read
Clinical

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

2 Min Read
Clinical

Dementia risk factors differ by ethnicity, according to new research

2 Min Read
Clinical

Researchers investigate how endocannabinoids regulate the brain’s stress response

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
  • Mental Health
Follow US

© 2024 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?